Profile for Outlook Therapeutics Inc. (OTLK)

$ 1.31   0.02 (+1.55%) Volume: 2.57m 4:00 PM EDT 6-Jul-2020
After Hours:  $ 1.32   0.01 (+0.76%) Volume: 12.61k 5:37 PM EDT 6-Jul-2020
Business Description:
Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.
Address: 7 Clarke Drive, Cranbury, NJ, USA, 08512
Telephone: +1 609 619-3990 Website: https://www.outlooktherapeutics.com
Facsimile: N/A Email: [email protected]
Details
CEO: N/A
Employees: 14 Market Cap: 160.27m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1649989
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)